WHWK · Whitehawk Therapeutics, Inc.
$3.70
+0.00 (+0.00%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$213.21M
Shares
57.01M
Volume · Oct 5
289.14K
Avg daily vol (3M)
391.84K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.70
Open$3.81
Day$3.66–3.81
52W close$1.94–5.10
Avg vol 30d313K
Short int2.7M · 4.8% float · 9.3d
Short vol33%
Last earningsMar 18, 2025
DataJan 2020–Oct 2026
Filing10-Q · Aug 6
Up next
filed Aug 6, 2026
call held Mar 18, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$79.83M
Trailing 12 months
Revenue growth YoY
-72.5%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-32.5%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$189.98M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+20.0%
Year over year · more shares
Price change (1Y)
+90.7%
Trailing year
Short interest
4.8%
Latest settlement · 9.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Neutral
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−2%
below
Price vs 50-day avg
−13%
below
RSI (14)
33
neutral
MACD trend
Negative
52-week position
56%
mid-range
Momentum
relative strength
1-month return
−20%
trailing
6-month return
+7%
trailing
YTD return
+53%
this year
Relative strength
−6%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+24% holders QoQ · +28 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.78% of float · ▼ -8.6% MoM · 9.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
77 holders — near 3-yr high, broad support
Squeeze score
50
elevated · 0–100
Fundamentals
Revenue growth
−73%
Y/Y
EPS growth
+86%
Y/Y
Free cash flow
$-98.0M
Quant / Vol
risk profile
Volatility
79%
annualized · 1-yr
Max drawdown
−28%
past year
ATR
5.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−2%
Neutral
Price vs 50-day avg
−13%
Bearish
RSI (14)
33
Neutral
MACD trend
Negative
Bearish
52-week position
56%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+24% holders QoQ · +28 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.78% of float · ▼ -8.6% MoM · 9.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
77 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $4 · 56%
Range high $5
vs 200-day avg -2%
vs 50-day avg -13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WHWK
this stock
Whitehawk Therapeutics, Inc.
|
$213.21M | +52.9% | -72.5% | — | 4.8% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +11.3% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -4.8% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +544.3% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WHWK | -1.1% | -20.1% | +6.6% | -1.6% | +52.9% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -0.9% | -19.6% | -5.6% | -2.5% | +40.0% |